-
-
-
-
-
-
-
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
-
-
-
-
-
-
-
Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald As '26 Catalysts Already Credited
-
-
-
-
-
-
-
Merck shares fall as 2026 guidance disappoints despite solid Q4 results
-
-
-
-
-
-
-
Analysts cautious following Merck’s CMD, Morgan Stanley flags near-term risks
-
-
-
-
-
-
-
Merck (MRK) Tops Q2 EPS by 10c; narrows forecast
-
-
-
-
-
-
-
Merck posts higher profit, puts tariffs cost at $200 million
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines – MRK
-
1,217,303 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

